In pediatric stroke, advancements have been made in diagnosis, treatment, and outcomes; however, existing gaps still need to be addressed.

Patients not receiving thrombolytic treatments ... were performed daily during the study period. Study medication could be withheld in the event of hyperkalaemia >5.5 mmol/L and a serum creatinine ...

not receiving thrombolytic therapy, or unreperfused after thrombolysis. We selected this subgroup of patients (not thrombolysed, unreperfused and elderly) because they have a major risk of heart ...

After hours: November 22 at 5:28 PM EST Loading Chart for ANGO ...

One thing that makes several of them stand out is that drug use from their recent or distant past is not a major issue, is overshadowed by other issues or is not currently raising a furor in an ...

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro ...

Nov. 19, 2024 — A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in ... Promising Daily Tablet ...